Evangelia Kotzakioulafi

ORCID: 0000-0003-4841-1928
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diet and metabolism studies
  • Nutritional Studies and Diet
  • Diabetes Management and Research
  • Obesity, Physical Activity, Diet
  • Botulinum Toxin and Related Neurological Disorders
  • Diabetes and associated disorders
  • Neurological and metabolic disorders
  • Folate and B Vitamins Research
  • Parkinson's Disease Mechanisms and Treatments
  • Saffron Plant Research Studies
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Gastrointestinal motility and disorders
  • Pancreatic function and diabetes
  • Consumer Attitudes and Food Labeling
  • Pharmacological Effects and Assays
  • Phytochemical and Pharmacological Studies
  • COVID-19 diagnosis using AI
  • Artificial Intelligence in Healthcare and Education
  • Flavonoids in Medical Research
  • COVID-19 and healthcare impacts
  • Medicinal Plants and Bioactive Compounds
  • Sodium Intake and Health
  • Machine Learning in Healthcare
  • Sulfur Compounds in Biology
  • Neuropeptides and Animal Physiology

Aristotle University of Thessaloniki
2020-2024

AHEPA University Hospital
2018-2024

Alexander Technological Educational Institute of Thessaloniki
2019

To investigate the effect of normalizing vitamin B12 (B12) levels with oral (methylcobalamin) 1000 μg/day for one year in patients diabetic neuropathy (DN). In this prospective, double-blind, placebo-controlled trial, 90 type 2 diabetes on metformin at least four years and both peripheral autonomic DN were randomized to an active treatment group (n = 44) receiving a control 46) placebo. All had less than 400 pmol/L. Subjects underwent measurements sural nerve conduction velocity (SNCV),...

10.3390/nu13020395 article EN Nutrients 2021-01-27

Aim: To investigate the efficacy of Superoxide Dismutase, Alpha Lipoic Acid, Acetyl L-Carnitine, and Vitamin B12 (B12) in one tablet Diabetic Neuropathy (DN). Patients–methods: In this prospective, double-blind, placebo-controlled study, 85 patients with Diabetes Mellitus Type 2 (DMT2) were randomly assigned, either to receive combination four elements (active group, n = 43), or placebo (n 42) for 12 months. We used Michigan Screening Instrument Questionnaire Examination (MNSIQ MNSIE),...

10.3390/nu12113254 article EN Nutrients 2020-10-23

Dietary patterns may have a role in the prevention of functional gastrointestinal disorders (FGIDs). The current study aimed at examining association between FGIDs and adherence to Mediterranean diet (MD) among elementary school children (ESC), as well high students (HSS). In prospective cohort study, data from 1116 subjects (387 ESC 448 HSS) aged 6–18 years were collected. FGID identification was based on Questionnaire Pediatric Gastrointestinal Symptoms-Rome III (QPGS-RIII). Adherence MD...

10.3390/nu11061283 article EN Nutrients 2019-06-06

Background: Pregnant women with type 1 diabetes mellitus (T1DM) face an elevated risk of complications for both themselves and their newborns. Experts recommend strict glycemic control. The advanced hybrid closed-loop (AHCL) system, though not officially approved pregnant T1DM patients, is promising optimal Methods: We collected CGM metrics, HbA1c levels, insulin pump settings, doses from a 33-year-old woman 23-year history the 6th week gestation to birth. She was initially on continuous...

10.3390/jcm13051441 article EN Journal of Clinical Medicine 2024-03-01

Introduction-Background: Data from experimental trials show that Crocus sativus L. (saffron) is considered to improve glycemia, lipid profile, and blood pressure reduce oxidative stress. So far, clinical have been conducted in individuals with metabolic syndrome Diabetes Mellitus type 2 (DMT-2). The purpose of this study assess the effectiveness saffron 1 (DMT-1). 61 DMT-1, mean age 48 years old (48.3 ± 14.6), 26 females (42.6%) were randomized receive a new oral supplement sachets...

10.3390/nu16132089 article EN Nutrients 2024-06-29

Type 1 diabetes mellitus (T1DM) patients occasionally develop disordered eating behaviors, leading to insulin manipulation without medical consultation, targeting achieve weight control. In clinical practice, the Diabetes Eating Problem Survey-Revised Version (DEPS-R) questionnaire has been used evaluate disorders in T1DM patients. This study was conducted validate factor structure of Greek version DEPS-R using Confirmatory Factor Analysis (CFA), investigate its reliability and convergent...

10.3390/nu13072375 article EN Nutrients 2021-07-12

To compare in terms of glycemic variability two premixed insulins, Premixed Human Insulin 30/70 (PHI) and Biphasic Aspart 30 (BiAsp30), using Continuous Glucose Monitoring (CGM) to estimate the correlation Glycated Albumin (GA) Fructosamine (FA) with CGM data. Patients-Data: A total 36 well-controlled patients type 2 Diabetes Mellitus (T2DM) underwent 7-day PHI subsequently BiAsp30. GA FA were measured at first last day each week CGM. BiAsp30 was associated lower Average Blood (ABG) during...

10.3390/jcm10091982 article EN Journal of Clinical Medicine 2021-05-05

Since the beginning of COVID-19 pandemic, 195 million people have been infected and 4.2 died from disease or its side effects. Physicians, healthcare scientists medical staff continuously try to deal with overloaded hospital admissions, while in parallel, they identify meaningful correlations between severity patients their symptoms, comorbidities biomarkers. Artificial intelligence (AI) machine learning (ML) used recently many areas related healthcare. The main goal is manage effectively...

10.3390/jpm11121380 article EN Journal of Personalized Medicine 2021-12-17

Aim: To investigate the efficacy of Palmitoylethanolamide (PEA, 300 mg), Superoxide Dismutase (SOD, 70 UI), Alpha Lipoic Acid (ALA, vitamins B6 (1.5 B1 (1.1 B12 (2.5 mcg), E (7.5 nicotinamide (9 and minerals (Mg 30 mg, Zn 2.5 mg) in one tablet people with Diabetic Neuropathy (DN). Patients–methods: In present pilot study, 73 (age 63.0 ± 9.9 years, 37 women) type 2 Diabetes Mellitus (DMT2) (duration 17.5 7.3 years) DN were randomly assigned to receive either combination ten elements (2...

10.3390/nu16183045 article EN Nutrients 2024-09-10

Background: Continuous glucose monitoring has emerged as a promising tool in managing glycemic control for patients with type 2 diabetes admitted to the intensive care unit. This paper provides comprehensive review of potential benefits, challenges, and implications associated continuous utilization unit settings diabetic patients. Methods: In prospective observational study systems were applied adult two centers. Eighty randomly assigned into groups: one system standard monitoring, previous...

10.18203/2320-6012.ijrms20243685 article EN International Journal of Research in Medical Sciences 2024-11-30

Moxonidine is a centrally acting, anti-hypertensive medication that exerts additional metabolic properties. It unknown whether its effects are mediated by neurotransmitters or sympathetic tone regulators, including Neuropeptide Y (NPY). In this study, we evaluated the of moxonidine administration on serum NPY in humans. Methods: Ninety individuals with mild moderate arterial hypertension required monotherapy were categorized three age and gender-matched groups according to their Body Mass...

10.3390/endocrines3010004 article EN cc-by Endocrines 2022-01-12
Coming Soon ...